Swatch Group AG (0QJV)
London Exchange · UK · prices in GBP · close of 21 Oct 2026
Key indicators
| Last close | GBP 184.45 |
|---|---|
| 52-week range | 159.86 – 223.00 |
| Return, 1 month / 3 months | +3.7% / +6.0% |
| Return, 1 year / 3 years | +7.3% / −21.0% |
| Trend | Below its 200-day average |
| RSI (14) | 54 |
| Volatility (1 year) | 34.6% |
| Worst drawdown (1 year) | -23.6% |
| Average daily value traded | 3.40M GBP |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Swatch Group is a Swiss watchmaking company based in Biel/Bienne. It designs, makes and sells finished watches through a range of brands that span everyday plastic watches to mechanical luxury timepieces, and it also produces watch movements and components that it supplies to its own brands and to other watchmakers. Its customers include consumers worldwide who buy watches through retail partners and the company's own stores, along with jewellery and watch retailers and industrial buyers of components.
The shares are listed on the London Exchange in UK under the code 0QJV, and the price on this page is in pounds sterling (GBP). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Swatch Group AG (0QJV) trades on the London Exchange in UK. It last closed at GBP 184.45 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 2,000 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 7.3% and over the last three months it rose 6.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 44 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -1.7% | ||
| From 52-week high | -15.4% | ||
| Momentum | 54 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.0% | ||
| 6-month return | -0.7% | ||
| 12-month return, skipping the last month | 3.4% | ||
| Stability (higher is calmer) | 57 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 34.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.6% | ||
| Liquidity | 64 · Fair | Moderate trading activity. | |
| Average daily value traded | 3.40M GBP | ||
| Zero-volume days | 0.0% | ||
| Income | 26 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.6% |
|---|---|
| 1 month | +3.7% |
| 3 months | +6.0% |
| 6 months | −0.7% |
| 1 year | +7.3% |
| 3 years | −21.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 183.54 / 187.55 |
|---|---|
| Golden / death cross (60 days) | Death, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | GBX 0.0450 |
| 23 May 2025 | GBX 0.0450 |
| 13 May 2024 | GBX 0.0650 |
| 12 May 2023 | GBX 0.0600 |
| 27 May 2022 | GBX 0.0550 |
| 14 May 2021 | GBX 0.0350 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.